Subsequently, we discriminated all glioma samples into two groups of high and low HOXD‐AS2/IGF2BP2 expression in CGGA database, then GSEA and GSVA analysis were conducted to identify functional significance between groups. This evidence concerns the gene HOXD-AS2 and central nervous system cancer.